Concepts (223)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| T-Lymphocytes, Regulatory | 27 | 2025 | 74 | 5.310 |
Why?
|
| Forkhead Transcription Factors | 16 | 2025 | 78 | 2.900 |
Why?
|
| DNA-Binding Proteins | 13 | 2025 | 561 | 2.340 |
Why?
|
| Transcription Factors | 10 | 2025 | 735 | 1.980 |
Why?
|
| Ikaros Transcription Factor | 5 | 2025 | 9 | 1.400 |
Why?
|
| CD4-Positive T-Lymphocytes | 10 | 2019 | 279 | 1.260 |
Why?
|
| Receptors, Interleukin-2 | 10 | 2007 | 32 | 1.130 |
Why?
|
| Cell Differentiation | 12 | 2021 | 638 | 1.040 |
Why?
|
| Autoimmune Diseases | 5 | 2015 | 65 | 0.900 |
Why?
|
| T-Lymphocyte Subsets | 5 | 2014 | 91 | 0.890 |
Why?
|
| Lymphocyte Activation | 14 | 2025 | 249 | 0.890 |
Why?
|
| Interleukin-2 | 7 | 2025 | 91 | 0.690 |
Why?
|
| Antigens, Differentiation | 2 | 2019 | 22 | 0.680 |
Why?
|
| Mice | 34 | 2025 | 6644 | 0.660 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2019 | 69 | 0.620 |
Why?
|
| Mice, Inbred C57BL | 18 | 2025 | 1869 | 0.610 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 101 | 0.580 |
Why?
|
| Thymus Gland | 3 | 2025 | 76 | 0.560 |
Why?
|
| Immune Tolerance | 7 | 2014 | 68 | 0.550 |
Why?
|
| Animals | 38 | 2025 | 16992 | 0.540 |
Why?
|
| Autoimmunity | 6 | 2019 | 58 | 0.500 |
Why?
|
| Mice, Knockout | 15 | 2021 | 1035 | 0.480 |
Why?
|
| T-Lymphocytes | 4 | 2021 | 386 | 0.430 |
Why?
|
| Calcium | 3 | 2011 | 491 | 0.390 |
Why?
|
| Mice, Transgenic | 9 | 2021 | 665 | 0.380 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 7 | 2025 | 18 | 0.380 |
Why?
|
| Muscle, Skeletal | 2 | 2011 | 316 | 0.340 |
Why?
|
| Muscle Contraction | 1 | 2011 | 67 | 0.340 |
Why?
|
| Inflammatory Bowel Diseases | 4 | 2019 | 104 | 0.330 |
Why?
|
| Cell Proliferation | 6 | 2019 | 1455 | 0.310 |
Why?
|
| Phenotype | 4 | 2020 | 780 | 0.290 |
Why?
|
| Aging | 2 | 2011 | 783 | 0.280 |
Why?
|
| Coculture Techniques | 5 | 2011 | 109 | 0.280 |
Why?
|
| Homeostasis | 2 | 2025 | 192 | 0.270 |
Why?
|
| Calcium Signaling | 4 | 2011 | 107 | 0.270 |
Why?
|
| Signal Transduction | 6 | 2015 | 2157 | 0.270 |
Why?
|
| Gastritis | 1 | 2006 | 13 | 0.250 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2006 | 32 | 0.250 |
Why?
|
| B-Lymphocytes | 2 | 2006 | 189 | 0.240 |
Why?
|
| Mice, Inbred BALB C | 8 | 2010 | 694 | 0.230 |
Why?
|
| Nerve Tissue Proteins | 2 | 2019 | 386 | 0.220 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2019 | 184 | 0.210 |
Why?
|
| Immunomagnetic Separation | 1 | 2003 | 4 | 0.210 |
Why?
|
| Humans | 19 | 2019 | 43102 | 0.190 |
Why?
|
| Gene Expression Profiling | 3 | 2021 | 704 | 0.180 |
Why?
|
| Megakaryocytes | 1 | 2021 | 7 | 0.180 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2021 | 47 | 0.170 |
Why?
|
| Transforming Growth Factor beta | 4 | 2020 | 216 | 0.170 |
Why?
|
| Carrier Proteins | 2 | 2015 | 321 | 0.160 |
Why?
|
| Immediate-Early Proteins | 1 | 2020 | 49 | 0.150 |
Why?
|
| Leukemia, Experimental | 1 | 2018 | 4 | 0.150 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2018 | 8 | 0.150 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 2 | 2019 | 55 | 0.150 |
Why?
|
| Muscle Fibers, Skeletal | 3 | 2008 | 70 | 0.150 |
Why?
|
| Female | 15 | 2025 | 24698 | 0.140 |
Why?
|
| Membrane Proteins | 3 | 2014 | 561 | 0.140 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2018 | 38 | 0.140 |
Why?
|
| Inflammation | 2 | 2020 | 758 | 0.140 |
Why?
|
| Cell Movement | 3 | 2025 | 655 | 0.140 |
Why?
|
| Flow Cytometry | 5 | 2012 | 411 | 0.140 |
Why?
|
| Autoantigens | 2 | 2011 | 87 | 0.130 |
Why?
|
| Neoplastic Stem Cells | 1 | 2018 | 99 | 0.130 |
Why?
|
| Hypergammaglobulinemia | 1 | 2015 | 1 | 0.120 |
Why?
|
| Germinal Center | 1 | 2015 | 12 | 0.120 |
Why?
|
| Disease Models, Animal | 3 | 2016 | 1596 | 0.120 |
Why?
|
| Th1 Cells | 1 | 2015 | 97 | 0.120 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2014 | 97 | 0.110 |
Why?
|
| Interleukin-17 | 1 | 2015 | 53 | 0.110 |
Why?
|
| Integrin beta Chains | 1 | 2014 | 4 | 0.110 |
Why?
|
| T-Cell Antigen Receptor Specificity | 1 | 2014 | 4 | 0.110 |
Why?
|
| Integrins | 1 | 2014 | 54 | 0.110 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2016 | 163 | 0.100 |
Why?
|
| Glucocorticoid-Induced TNFR-Related Protein | 1 | 2013 | 4 | 0.100 |
Why?
|
| Calcium Channels | 2 | 2011 | 73 | 0.100 |
Why?
|
| Tumor Necrosis Factors | 1 | 2013 | 13 | 0.100 |
Why?
|
| Cell Culture Techniques | 2 | 2012 | 152 | 0.100 |
Why?
|
| Lymphocytes | 2 | 2021 | 124 | 0.100 |
Why?
|
| Liver Neoplasms | 1 | 2016 | 224 | 0.100 |
Why?
|
| Male | 8 | 2021 | 23409 | 0.090 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2012 | 50 | 0.090 |
Why?
|
| Smad7 Protein | 1 | 2011 | 5 | 0.090 |
Why?
|
| Muscle Proteins | 2 | 2008 | 51 | 0.090 |
Why?
|
| Excitation Contraction Coupling | 1 | 2011 | 2 | 0.090 |
Why?
|
| Thiadiazoles | 1 | 2011 | 6 | 0.090 |
Why?
|
| Pyrones | 1 | 2011 | 11 | 0.090 |
Why?
|
| Nifedipine | 1 | 2011 | 10 | 0.090 |
Why?
|
| Muscular Atrophy | 1 | 2011 | 13 | 0.090 |
Why?
|
| Anilides | 1 | 2011 | 28 | 0.090 |
Why?
|
| Nickel | 1 | 2011 | 23 | 0.090 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2011 | 26 | 0.090 |
Why?
|
| Cysteine Endopeptidases | 1 | 2011 | 64 | 0.090 |
Why?
|
| Caffeine | 1 | 2011 | 28 | 0.090 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2011 | 33 | 0.090 |
Why?
|
| Naphthalenes | 1 | 2011 | 38 | 0.090 |
Why?
|
| Calcium Channel Blockers | 1 | 2011 | 55 | 0.090 |
Why?
|
| Cytokines | 2 | 2006 | 678 | 0.090 |
Why?
|
| Electric Stimulation | 1 | 2011 | 186 | 0.080 |
Why?
|
| Cell Communication | 2 | 2008 | 114 | 0.080 |
Why?
|
| Brucella abortus | 1 | 2009 | 4 | 0.080 |
Why?
|
| Brucellosis | 1 | 2009 | 8 | 0.080 |
Why?
|
| RNA, Messenger | 3 | 2020 | 1271 | 0.080 |
Why?
|
| Cell Separation | 1 | 2010 | 94 | 0.080 |
Why?
|
| Gene Expression Regulation | 2 | 2021 | 1070 | 0.080 |
Why?
|
| Cell Lineage | 1 | 2010 | 104 | 0.080 |
Why?
|
| Spleen | 1 | 2010 | 204 | 0.080 |
Why?
|
| Sarcolemma | 1 | 2008 | 4 | 0.070 |
Why?
|
| Transport Vesicles | 1 | 2008 | 22 | 0.070 |
Why?
|
| Regeneration | 1 | 2008 | 32 | 0.070 |
Why?
|
| Interleukin-10 | 2 | 2007 | 87 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 652 | 0.070 |
Why?
|
| Receptors, IgE | 1 | 2008 | 22 | 0.070 |
Why?
|
| Clonal Anergy | 2 | 2007 | 5 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2008 | 183 | 0.070 |
Why?
|
| Coronary Artery Bypass | 1 | 2008 | 47 | 0.070 |
Why?
|
| Mast Cells | 1 | 2008 | 82 | 0.070 |
Why?
|
| Wiskott-Aldrich Syndrome Protein | 1 | 2007 | 2 | 0.070 |
Why?
|
| Wiskott-Aldrich Syndrome | 1 | 2007 | 6 | 0.070 |
Why?
|
| Models, Immunological | 2 | 2004 | 21 | 0.070 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2008 | 347 | 0.070 |
Why?
|
| Immunity, Mucosal | 1 | 2007 | 53 | 0.060 |
Why?
|
| Coronary Disease | 1 | 2008 | 123 | 0.060 |
Why?
|
| Cell Division | 2 | 2006 | 311 | 0.060 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 2006 | 7 | 0.060 |
Why?
|
| Antigens, Bacterial | 1 | 2007 | 144 | 0.060 |
Why?
|
| Intestinal Mucosa | 1 | 2007 | 134 | 0.060 |
Why?
|
| Immune System | 1 | 2006 | 41 | 0.060 |
Why?
|
| Transgenes | 1 | 2006 | 65 | 0.060 |
Why?
|
| Dendritic Cells | 1 | 2025 | 132 | 0.060 |
Why?
|
| Immunologic Techniques | 1 | 2004 | 12 | 0.050 |
Why?
|
| Antigen-Presenting Cells | 1 | 2004 | 31 | 0.050 |
Why?
|
| Antigens, Surface | 1 | 2004 | 52 | 0.050 |
Why?
|
| Epitopes | 1 | 2004 | 157 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2004 | 127 | 0.050 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2002 | 70 | 0.050 |
Why?
|
| Gene Library | 1 | 2002 | 62 | 0.050 |
Why?
|
| Models, Biological | 1 | 2006 | 712 | 0.050 |
Why?
|
| Healthcare Disparities | 1 | 2008 | 590 | 0.050 |
Why?
|
| Cloning, Molecular | 1 | 2002 | 314 | 0.050 |
Why?
|
| Cells, Cultured | 3 | 2011 | 1621 | 0.040 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2020 | 5 | 0.040 |
Why?
|
| Sodium Chloride | 1 | 2020 | 54 | 0.040 |
Why?
|
| Cell Line | 3 | 2008 | 1410 | 0.040 |
Why?
|
| Intestines | 1 | 2020 | 71 | 0.040 |
Why?
|
| Cell Polarity | 1 | 2020 | 57 | 0.040 |
Why?
|
| Protein Biosynthesis | 1 | 2020 | 132 | 0.040 |
Why?
|
| Hematopoiesis | 1 | 2018 | 27 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2019 | 2676 | 0.030 |
Why?
|
| Kidney | 1 | 2020 | 372 | 0.030 |
Why?
|
| Chromatin | 1 | 2018 | 186 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2008 | 1723 | 0.030 |
Why?
|
| Oxidative Stress | 2 | 2016 | 1003 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 2012 | 455 | 0.030 |
Why?
|
| Linoleic Acid | 1 | 2016 | 9 | 0.030 |
Why?
|
| Methionine | 1 | 2016 | 27 | 0.030 |
Why?
|
| Genes, myc | 1 | 2016 | 31 | 0.030 |
Why?
|
| Hepatocytes | 1 | 2016 | 80 | 0.030 |
Why?
|
| Choline | 1 | 2016 | 61 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2015 | 79 | 0.030 |
Why?
|
| Animals, Newborn | 2 | 2008 | 352 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2016 | 148 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 2 | 2008 | 306 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2014 | 209 | 0.030 |
Why?
|
| Colitis | 1 | 2014 | 71 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 300 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2016 | 532 | 0.020 |
Why?
|
| Liver | 1 | 2016 | 511 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2016 | 1285 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2013 | 150 | 0.020 |
Why?
|
| Mitochondria | 1 | 2016 | 523 | 0.020 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2011 | 21 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2011 | 53 | 0.020 |
Why?
|
| Lymphopenia | 1 | 2011 | 17 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2011 | 74 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2011 | 62 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2011 | 105 | 0.020 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2011 | 60 | 0.020 |
Why?
|
| Hela Cells | 1 | 2011 | 376 | 0.020 |
Why?
|
| Skin | 1 | 2011 | 187 | 0.020 |
Why?
|
| Diet | 1 | 2016 | 826 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2011 | 196 | 0.020 |
Why?
|
| Pregnancy Proteins | 1 | 2008 | 5 | 0.020 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2008 | 11 | 0.020 |
Why?
|
| Membrane Fusion | 1 | 2008 | 11 | 0.020 |
Why?
|
| Phosphotyrosine | 1 | 2008 | 23 | 0.020 |
Why?
|
| Extracellular Fluid | 1 | 2008 | 15 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2011 | 526 | 0.020 |
Why?
|
| Pericytes | 1 | 2008 | 21 | 0.020 |
Why?
|
| Synaptophysin | 1 | 2008 | 6 | 0.020 |
Why?
|
| Adult | 3 | 2012 | 13872 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 592 | 0.020 |
Why?
|
| Utilization Review | 1 | 2008 | 17 | 0.020 |
Why?
|
| Protein Binding | 1 | 2011 | 1082 | 0.020 |
Why?
|
| Protein Transport | 1 | 2008 | 296 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2008 | 139 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2008 | 224 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2008 | 408 | 0.020 |
Why?
|
| Ligands | 1 | 2008 | 388 | 0.020 |
Why?
|
| Adoptive Transfer | 1 | 2007 | 53 | 0.020 |
Why?
|
| Manganese | 1 | 2008 | 92 | 0.020 |
Why?
|
| Aged | 2 | 2012 | 8214 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2008 | 224 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2009 | 549 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2008 | 329 | 0.010 |
Why?
|
| Gene Silencing | 1 | 2006 | 154 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 2853 | 0.010 |
Why?
|
| Cell Death | 1 | 2006 | 278 | 0.010 |
Why?
|
| Logistic Models | 1 | 2008 | 1009 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 1081 | 0.010 |
Why?
|
| Middle Aged | 2 | 2012 | 12222 | 0.010 |
Why?
|
| Kinetics | 1 | 2006 | 695 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2007 | 536 | 0.010 |
Why?
|
| Methicillin Resistance | 1 | 2002 | 12 | 0.010 |
Why?
|
| Smad3 Protein | 1 | 2002 | 12 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2007 | 1546 | 0.010 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2002 | 26 | 0.010 |
Why?
|
| Genes, Bacterial | 1 | 2002 | 91 | 0.010 |
Why?
|
| Neutralization Tests | 1 | 2002 | 57 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2002 | 196 | 0.010 |
Why?
|
| Staphylococcus aureus | 1 | 2002 | 94 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2002 | 192 | 0.010 |
Why?
|
| Young Adult | 1 | 2012 | 5080 | 0.010 |
Why?
|
| Risk Factors | 1 | 2008 | 3994 | 0.010 |
Why?
|
| United States | 1 | 2008 | 5205 | 0.010 |
Why?
|